Holen Sie sich die Stockscreener-App
235.87
0.71%
1.82
Schlusskurs vom Vortag:
$234.05
Offen:
$232.07
24-Stunden-Volumen:
260.94K
Relative Volume:
0.83
Marktkapitalisierung:
$6.83B
Einnahmen:
$290.51M
Nettoeinkommen (Verlust:
$89.16M
KGV:
78.89
EPS:
2.99
Netto-Cashflow:
$119.18M
1W Leistung:
+9.60%
1M Leistung:
+19.09%
6M Leistung:
+73.22%
1J Leistung:
+27.83%
1-Tages-Spanne:
$231.51
$237.19
1-Wochen-Bereich:
$213.83
$241.65
52-Wochen-Spanne:
$122.80
$241.65
Krystal Biotech Inc Stock (KRYS) Company Profile
Firmenname
Krystal Biotech Inc
Sektor
Branche
Telefon
(412) 586-5830
Adresse
2100 WHARTON STREET, PITTSBURGH, PA
Vergleichen Sie KRYS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
235.49 | 6.79B | 290.51M | 89.16M | 119.18M | 2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.54 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
699.82 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
417.91 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
891.83 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.92 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-05 | Eingeleitet | Jefferies | Buy |
| 2024-08-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-11-20 | Eingeleitet | Goldman | Buy |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-10-12 | Eingeleitet | Citigroup | Buy |
| 2023-09-07 | Eingeleitet | Berenberg | Buy |
| 2023-04-18 | Eingeleitet | Stifel | Buy |
| 2023-02-28 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-25 | Herabstufung | Goldman | Buy → Neutral |
| 2022-01-18 | Eingeleitet | BofA Securities | Buy |
| 2021-07-20 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-18 | Eingeleitet | B. Riley FBR | Buy |
| 2020-06-04 | Eingeleitet | Evercore ISI | Outperform |
| 2019-09-24 | Eingeleitet | Goldman | Neutral |
| 2019-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-24 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-06-24 | Bestätigt | H.C. Wainwright | Buy |
| 2019-05-30 | Eingeleitet | Guggenheim | Buy |
| 2018-09-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Krystal Biotech Inc Aktie (KRYS) Neueste Nachrichten
Hood River Capital Management LLC Purchases 8,379 Shares of Krystal Biotech, Inc. $KRYS - MarketBeat
282,706 Shares in Krystal Biotech, Inc. $KRYS Bought by Norges Bank - MarketBeat
JPMorgan Chase & Co. Sells 9,621 Shares of Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech Insider Sold Shares Worth $11,007,447, According to a Recent SEC Filing - marketscreener.com
Suma Krishnan Sells 25,000 Shares of Krystal Biotech (NASDAQ:KRYS) Stock - MarketBeat
Krystal Biotech (KRYS) president Krishnan sells shares worth $3.3 million - Investing.com
Krystal Biotech (NASDAQ:KRYS) Sets New 52-Week HighTime to Buy? - MarketBeat
How Krystal Biotech Inc. (4KB) stock trades after earningsJobs Report & High Win Rate Trade Alerts - Newser
Krystal Biotech stock hits all-time high of 221.91 USD By Investing.com - Investing.com Nigeria
Edgestream Partners L.P. Buys Shares of 19,678 Krystal Biotech, Inc. $KRYS - MarketBeat
Why Krystal Biotech Inc. stock could rally in 2025Trade Entry Report & Entry Point Strategy Guides - Newser
How Krystal Biotech Inc. stock reacts to oil pricesWeekly Market Summary & Stock Market Timing Techniques - Newser
Krystal Biotech stock hits all-time high of 221.91 USD - Investing.com
Will Krystal Biotech Inc. stock outperform growth indexes2025 Key Highlights & High Conviction Investment Ideas - Newser
Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? - The Motley Fool
Is Krystal Biotech Inc. (4KB) stock considered safe havenJuly 2025 Update & AI Driven Price Predictions - Newser
Will Krystal Biotech Inc. (4KB) stock issue positive guidance2025 Fundamental Recap & Daily Technical Forecast Reports - Newser
Will Krystal Biotech Inc. (4KB) stock announce a stock splitJuly 2025 Movers & Comprehensive Market Scan Insights - Newser
Creative Planning Has $1.15 Million Position in Krystal Biotech, Inc. $KRYS - MarketBeat
Is TTK Prestige Limited Undervalued or Overvalued Fair Value ExplainedMarket Liquidity Analysis & Discover Strategies with Fellow Traders - earlytimes.in
Price-Driven Insight from (KRYS) for Rule-Based Strategy - news.stocktradersdaily.com
Universal Beteiligungs und Servicegesellschaft mbH Sells 8,619 Shares of Krystal Biotech, Inc. $KRYS - MarketBeat
Pharma News: Will Krystal Biotech Inc. stock benefit from AI adoptionWatch List & Stepwise Swing Trade Plans - BỘ NỘI VỤ
Will Krystal Biotech Inc. stock benefit from AI adoptionWeekly Gains Report & Daily Momentum Trading Reports - BỘ NỘI VỤ
Krystal Biotech (NASDAQ:KRYS) Reaches New 1-Year HighWhat's Next? - MarketBeat
Krystal Biotech, Inc. (KRYS) Stock Forecasts - Yahoo Finance
Why Krystal Biotech Inc. stock is considered a top pickTreasury Yields & Detailed Earnings Play Alerts - BỘ NỘI VỤ
Rhenman & Partners Asset Management AB Sells 5,000 Shares of Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech, Inc. to Participate in 8th Annual Evercore Healthcare Conference on December 3, 2025 - Quiver Quantitative
Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference - The Manila Times
Krystal Biotech (NASDAQ: KRYS) at 8th Evercore Conference with 10:00 a.m. ET fireside chat - Stock Titan
Handelsbanken Fonder AB Sells 7,500 Shares of Krystal Biotech, Inc. $KRYS - MarketBeat
Cynosure Group LLC Acquires 2,016 Shares of Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech stock hits 52-week high at 213.09 USD By Investing.com - Investing.com Nigeria
Evercore ISI Reiterates Buy Rating on Krystal Biotech (KRYS), Sets $218 PT - MSN
How Investors Are Reacting To Krystal Biotech (KRYS) Surging Revenue and Global VYJUVEK Expansion - Sahm
Krystal Biotech stock hits 52-week high at 213.09 USD - Investing.com India
Will Krystal Biotech Inc. stock outperform Nasdaq indexWeekly Trading Summary & Stock Portfolio Risk Control - newser.com
Krystal Biotech (KRYS) Secures FDA Orphan Status for Hailey-Hail - GuruFocus
Why Krystal Biotech Inc. (4KB) stock is a must watch tickerAnalyst Upgrade & Technical Pattern Based Signals - newser.com
How strong dollar benefits Krystal Biotech Inc. (4KB) stock2025 Support & Resistance & Weekly Momentum Picks - newser.com
Is Krystal Biotech Inc. stock a defensive play in 2025July 2025 Macro Moves & Daily Growth Stock Investment Tips - newser.com
Can Krystal Biotech Inc. stock sustain market leadershipJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
Can Krystal Biotech Inc. (4KB) stock expand revenue streamsEarnings Recap Summary & Weekly High Return Stock Opportunities - newser.com
Can Krystal Biotech Inc. hit a new high this monthJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - newser.com
Can Krystal Biotech Inc. (4KB) stock sustain revenue momentumJuly 2025 Retail & Verified Momentum Watchlists - newser.com
Finanzdaten der Krystal Biotech Inc-Aktie (KRYS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):